CSI with SIES Institute of Chromatography and Spectroscopy to organise symposium
Symposium to be held in Navi Mumbai on December 18 and 19, 2014
Chromatographic Society of India (CSI) has announced a two-day…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Asia Pharma Expo 2015 to be held in Bangladesh
More than 470 exhibiting companies from 28 countries will participate
Asia Pharma Expo 2015 (APE2015), the 7th international…
Social Media Week focuses on ‘Impact of Social Media in Healthcare Sector’
Patient engagement and community building are the unexplored mediums
Social Media Week (SMW), a worldwide event exploring the…
Select Biosciences India organises triconference in Mumbai
Triconference witnesses 250 attendees from India and abroad
Drug Discovery India 2014, Drug Metabolism & Discovery ADMET,…
17th Annual IDMA – APA Pharmaceutical Analysts’ Convention held
The theme for this year’s convention was, 'Challenges in Global Quality Management'The Indian Drug Manufacturers’ Association…
Glenmark enrols first patient for phase II trial of GBR 500
The company out licensed Vatelizumab (GBR 500) to Sanofi for all indications in 2011
Ranbaxy obtains US FDA approval to market fenofibrate capsules
Fenofibrate capsules are indicated for primary hypercholesterolemia and mixed dyslipidemia. In addition, it is indicated for…
Glenmark Generics receives final ANDA approval for Omeprazole DR capsules
It is a generic version of Prilosec by AstraZeneca
Study confirms positive safety profile and effectiveness of Pradaxa in atrial fibrillation patients
The US FDA Medicare study of 134,000 patients demonstrates benefits such as a significantly reduced risk of ischaemic stroke, a…
Phase III efficacy clinical study results of Sanofi’s Dengue vaccine candidate published
Study successfully met primary objective and confirms high efficacy against severe dengue and hospitalisation
Sanofi Pasteur,…